DMD and cardiomyopathy: Assessment of changes occurring in cardiac muscle in mdx mouse model suggested that restoration of cardiac myocyte dystrophin levels as low as 4–15% of the wild type mice can delay or even partially ameliorate the effects of cardiomyopathy in the mdx mice [24].